As a firm, we are well equipped to advise in the Life Sciences specific areas of IP law, including the ever-evolving area of Supplementary Protections Certificates (SPCs). Our Life Sciences professionals understand client perspective, with a significant number having worked within industry management positions. These attorneys are highly skilled in freedom to operate projects, product portfolio management and launch strategies.
The Avidity IP Life Sciences team fully appreciates the broader commercial implications of patents and applications; our senior attorneys have undertaken external IP due diligence within the context of investment planning, e.g. stock market listing/IPO, as well as other transactional work, such as company mergers and acquisitions. Concerning more contentious matters, our attorneys have established close working relationships with well-regarded members of chambers and technical experts to support litigation in this technical area.